Overview

Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants

Status:
Terminated
Trial end date:
2018-12-26
Target enrollment:
Participant gender:
Summary
This is a single-arm, open label, interventional, multi-center, phase 4 pilot study.
Phase:
Phase 4
Details
Lead Sponsor:
Merck KGaA
Merck KGaA, Darmstadt, Germany
Collaborator:
Merck Serono Co., Ltd., China
Treatments:
Bisoprolol